Clinical Trial Update: Bone Properties in Hypoparathyroidism: Effects of PTH [Phase 2, Phase 3]

View source ↗

Summary

The document reports results from Phase 2 and Phase 3 trials evaluating the effects of parathyroid hormone on bone properties in people with hypoparathyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Parathyroid Hormone (PTH) (parathyroid hormone)

Snippet

Sponsor: John P. Bilezikian | Conditions: Hypoparathyroidism | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-07-16